Back to search
FDAFDA · Food and drugs·Recall number D-1169-2014

Clalis capsules, 50 mg, 6 -count bottle ( labeling is in foreign language)

Published March 26, 2014 · Recall initiated: June 27, 2013

Summary

FDA records drug Class I recall D-1169-2014, published March 26, 2014 and initiated June 27, 2013. Recalling firm: Fabscout Entertainment, Inc; Status: Terminated; Lot: All lots. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fabscout Entertainment, Inc
Distributor
Nationwide and France
Lot
All lots
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Clalis capsules, 50 mg, 6 -count bottle ( labeling is in foreign language) recalled?

Yes. FDA published recall D-1169-2014 on March 26, 2014. Reported hazard: Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit